Transforming Growth Factor-β: Activation by Neuraminidase and Role in Highly Pathogenic H5N1 Influenza Pathogenesis

English version České info

Transforming growth factor-beta (TGF-β), a multifunctional cytokine regulating several immunologic processes, is expressed by virtually all cells as a biologically inactive molecule termed latent TGF-β (LTGF-β). We have previously shown that TGF-β activity increases during influenza virus infection in mice and suggested that the neuraminidase (NA) protein mediates this activation. In the current study, we determined the mechanism of activation of LTGF-β by NA from the influenza virus A/Gray Teal/Australia/2/1979 by mobility shift and enzyme inhibition assays. We also investigated whether exogenous TGF-β administered via a replication-deficient adenovirus vector provides protection from H5N1 influenza pathogenesis and whether depletion of TGF-β during virus infection increases morbidity in mice. We found that both the influenza and bacterial NA activate LTGF-β by removing sialic acid motifs from LTGF-β, each NA being specific for the sialic acid linkages cleaved. Further, NA likely activates LTGF-β primarily via its enzymatic activity, but proteases might also play a role in this process. Several influenza A virus subtypes (H1N1, H1N2, H3N2, H5N9, H6N1, and H7N3) except the highly pathogenic H5N1 strains activated LTGF-β in vitro and in vivo. Addition of exogenous TGF-β to H5N1 influenza virus–infected mice delayed mortality and reduced viral titers whereas neutralization of TGF-β during H5N1 and pandemic 2009 H1N1 infection increased morbidity. Together, these data show that microbe-associated NAs can directly activate LTGF-β and that TGF-β plays a pivotal role protecting the host from influenza pathogenesis.

Vyšlo v časopise: Transforming Growth Factor-β: Activation by Neuraminidase and Role in Highly Pathogenic H5N1 Influenza Pathogenesis. PLoS Pathog 6(10): e32767. doi:10.1371/journal.ppat.1001136
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001136

Souhrn

Zdroje

1. MortyRE

KonigshoffM

EickelbergO

2009 Transforming Growth Factor-{beta} Signaling across Ages: From Distorted Lung Development to Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 6 607 613

2. TaipaleJ

MiyazonoK

HeldinCH

Keski-OjaJ

1994 Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol 124 171 181

3. PiekE

HeldinCH

Ten DijkeP

1999 Specificity, diversity, and regulation in TGF-beta superfamily signaling. Faseb J 13 2105 2124

4. GentryLE

LioubinMN

PurchioAF

MarquardtH

1988 Molecular events in the processing of recombinant type 1 pre-pro- transforming growth factor beta to the mature polypeptide. Mol Cell Biol 8 4162 4168

5. LawrenceDA

PircherR

Kryceve-MartinerieC

JullienP

1984 Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol 121 184 188

6. MungerJS

HarpelJG

GleizesPE

MazzieriR

NunesI

1997 Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int 51 1376 1382

7. ShaX

YangL

GentryLE

1991 Identification and analysis of discrete functional domains in the pro region of pre-pro-transforming growth factor beta 1. J Cell Biol 114 827 839

8. YoungGD

Murphy-UllrichJE

2004 Molecular Interactions That Confer Latency to Transforming Growth Factor-{beta}. J Biol Chem 279 38032 38039

9. AnnesJP

MungerJS

RifkinDB

2003 Making sense of latent TGFbeta activation. J Cell Sci 116 217 224

10. AluwihareP

MungerJS

2008 What the lung has taught us about latent TGF-beta activation. Am J Respir Cell Mol Biol 39 499 502

11. Barcellos-HoffMH

DixTA

1996 Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol 10 1077 1083

12. VodovotzY

CheslerL

ChongH

KimSJ

SimpsonJT

1999 Regulation of transforming growth factor beta1 by nitric oxide. Cancer Res 59 2142 2149

13. BrownPD

WakefieldLM

LevinsonAD

SpornMB

1990 Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors 3 35 43

14. LawrenceDA

PircherR

JullienP

1985 Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions. Biochem Biophys Res Commun 133 1026 1034

15. JenkinsG

2008 The role of proteases in transforming growth factor-beta activation. Int J Biochem Cell Biol 40 1068 1078

16. Schultz-CherryS

ChenH

MosherDF

MisenheimerTM

KrutzschHC

1995 Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem 270 7304 7310

17. Schultz-CherryS

LawlerJ

Murphy-UllrichJE

1994 The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. J Biol Chem 269 26783 26788

18. Schultz-CherryS

RibeiroS

GentryL

Murphy-UllrichJE

1994 Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J Biol Chem 269 26775 26782

19. Schultz-CherryS

Murphy-UllrichJE

1993 Thrombospondin causes activation of latent transforming growth factor- beta secreted by endothelial cells by a novel mechanism [published erratum appears in J Cell Biol 1993 Sep;122(5):following 1143]. J Cell Biol 122 923 932

20. Murphy-UllrichJE

PoczatekM

2000 Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev 11 59 69

21. TaylorAW

2009 Review of the activation of TGF-{beta} in immunity. J Leukoc Biol 85 29 33

22. KothLL

AlexB

HawgoodS

NeadMA

SheppardD

2007 Integrin beta6 mediates phospholipid and collectin homeostasis by activation of latent TGF-beta1. Am J Respir Cell Mol Biol 37 651 659

23. GanttKR

Schultz-CherryS

RodriguezN

JeronimoSM

NascimentoET

2003 Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages. J Immunol 170 2613 2620

24. OmerFM

de SouzaJB

CorranPH

SultanAA

RileyEM

2003 Activation of transforming growth factor beta by malaria parasite-derived metalloproteinases and a thrombospondin-like molecule. J Exp Med 198 1817 1827

25. AungH

WuM

JohnsonJL

HirschCS

ToossiZ

2005 Bioactivation of latent transforming growth factor beta1 by Mycobacterium tuberculosis in human mononuclear phagocytes. Scand J Immunol 61 558 565

26. WaghabiMC

KeramidasM

FeigeJJ

Araujo-JorgeTC

BaillyS

2005 Activation of transforming growth factor beta by Trypanosoma cruzi. Cell Microbiol 7 511 517

27. Schultz-CherryS

HinshawVS

1996 Influenza virus neuraminidase activates latent transforming growth factor beta. J Virol 70 8624 8629

28. KimNY

KimHG

KimYH

ChungIS

YangJM

2008 Expression and characterization of human N-acetylglucosaminyltransferases and alpha2,3-sialyltransferase in insect cells for in vitro glycosylation of recombinant erythropoietin. J Microbiol Biotechnol 18 383 391

29. BenureauY

HuetJC

CharpilienneA

PoncetD

CohenJ

2005 Trypsin is associated with the rotavirus capsid and is activated by solubilization of outer capsid proteins. J Gen Virol 86 3143 3151

30. ShawML

StoneKL

ColangeloCM

GulcicekEE

PaleseP

2008 Cellular proteins in influenza virus particles. PLoS Pathog 4 e1000085

31. HoffmannE

StechJ

LenevaI

KraussS

ScholtissekC

2000 Characterization of the influenza A virus gene pool in avian species in southern China: was H6N1 a derivative or a precursor of H5N1? J Virol 74 6309 6315

32. DybingJK

Schultz-CherryS

SwayneDE

SuarezDL

PerdueML

2000 Distinct pathogenesis of hong kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses. J Virol 74 1443 1450

33. TaylorG

1996 Sialidases: structures, biological significance and therapeutic potential. Current Opinion in Structural Biology 6 830 837

34. MiyazonoK

HeldinCH

1989 Role for carbohydrate structures in TGF-beta 1 latency. Nature 338 158 160

35. WakefieldLM

WinokurTS

HollandsRS

ChristophersonK

LevinsonAD

1990 Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest 86 1976 1984

36. ZouZ

SunPD

2006 An improved recombinant mammalian cell expression system for human transforming growth factor-[beta]2 and -[beta]3 preparations. Protein Expression and Purification 50 9 17

37. CauthenAN

SwayneDE

Schultz-CherryS

PerdueML

SuarezDL

2000 Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans. J Virol 74 6592 6599

38. MatsuokaY

SwayneDE

ThomasC

Rameix-WeltiMA

NaffakhN

2009 Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice. J Virol 83 4704 4708

39. KoliK

MyllarniemiM

Keski-OjaJ

KinnulaVL

2008 Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal 10 333 342

40. VictorT

SolovyanJK-O

2006 Proteolytic activation of latent TGF-? precedes caspase-3 activation and enhances apoptotic death of lung epithelial cells. J Cell Phys 207 445 453

41. MungerJS

HuangX

KawakatsuH

GriffithsMJ

DaltonSL

1999 The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96 319 328

42. PittetJF

GriffithsMJ

GeiserT

KaminskiN

DaltonSL

2001 TGF-beta is a critical mediator of acute lung injury. J Clin Invest 107 1537 1544

43. SheppardD

2001 Integrin-mediated activation of transforming growth factor-beta(1) in pulmonary fibrosis. Chest 120 49S 53S

44. SheppardD

2005 Integrin-mediated activation of latent transforming growth factor beta. Cancer Metastasis Rev 24 395 402

45. BosseY

Rola-PleszczynskiM

2007 Controversy surrounding the increased expression of TGF beta 1 in asthma. Respir Res 8 66

46. LiMO

WanYY

SanjabiS

RobertsonAK

FlavellRA

2006 Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24 99 146

47. KidoH

OkumuraY

YamadaH

LeTQ

YanoM

2007 Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents. Curr Pharm Des 13 405 414

48. ZhangL

KatzJM

GwinnM

DowlingNF

KhouryMJ

2009 Systems-based candidate genes for human response to influenza infection. Infection, Genetics and Evolution 9 1148 1157

49. KidoH

MurakamiM

ObaK

ChenY

TowatariT

1999 Cellular proteinases trigger the infectivity of the influenza A and Sendai viruses. Mol Cells 9 235 244

50. RoweRK

BrodySL

PekoszA

2004 Differentiated cultures of primary hamster tracheal airway epithelial cells. In Vitro Cell Dev Biol Anim 40 303 311

51. GordonKJ

BlobeGC

2008 Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim Biophys Acta 1782 197 228

52. FitzpatrickDR

Bielefeldt-OhmannH

1999 Transforming growth factor beta in infectious disease: always there for the host and the pathogen. Trends Microbiol 7 232 236

53. ReedSG

1999 TGF-beta in infections and infectious diseases. Microbes Infect 1 1313 1325

54. OmerFM

KurtzhalsJA

RileyEM

2000 Maintaining the immunological balance in parasitic infections: a role for TGF-beta? Parasitol Today 16 18 23

55. OmerFM

RileyEM

1998 Transforming growth factor beta production is inversely correlated with severity of murine malaria infection. J Exp Med 188 39 48

56. BaigentSJ

McCauleyJW

2001 Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture. Virus Res 79 177 185

57. ShtyryaY

MochalovaL

VoznovaG

RudnevaI

ShilovA

2009 Adjustment of receptor-binding and neuraminidase substrate specificities in avian-human reassortant influenza viruses. Glycoconj J 26 99 109

58. RichmondJY

McKinneyRWIII

1993 Biosafety in microbiological and biomedical laboratories Atlanta, GA U.S. Department of Health and Human Services, Centers for Disease Control 26 36

59. JonesJC

TurpinEA

BultmannH

BrandtCR

Schultz-CherryS

2006 Inhibition of Influenza Virus Infection by a Novel Antiviral Peptide That Targets Viral Attachment to Cells. J Virol 80 11960 11967

60. ReedLJ

MuenchH

1938 A simple method of estimating fifty percent endpoints. Am J Hyg 27 493 497

61. JohanssonBE

BucherDJ

KilbourneED

1989 Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J Virol 63 1239 1246

62. PotierM

MameliL

BelisleM

DallaireL

MelanconSB

1979 Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Analytical Biochemistry 94 287 296

63. AbeM

HarpelJG

MetzCN

NunesI

LoskutoffDJ

1994 An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 216 276 284

64. NeumannG

WatanabeT

ItoH

WatanabeS

GotoH

1999 Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96 9345 9350

65. HoffmannE

KraussS

PerezD

WebbyR

WebsterRG

2002 Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20 3165 3170

66. DaschJ

PaceD

WaegellW

InenagaD

EllingsworthL

1989 Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. J Immunol 142 1536 1541

67. GauldieJ

GaltT

BonniaudP

RobbinsC

KellyM

2003 Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia. Am J Pathol 163 2575 2584

68. RobertsonJV

NathuZ

NajjarA

DwivediD

GauldieJ

2007 Adenoviral gene transfer of bioactive TGFbeta1 to the rodent eye as a novel model for anterior subcapsular cataract. Mol Vis 13 457 469